You are here
- Home
- Therapy Areas
- Gastrointestinal
Association Between Low Dose Acetylsalicylic Acid (ASA) and Proton Pump Inhibitors and Risk of Acute Myocardial Infarction or Coronary Death
- Disease
- gastroesophageal reflux disease
- Drug Name
- Nexium
- Generic Name
- esomeprazole
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- Non-Interventional Study
- Start Date
- Jun 20, 2011
- Study Name
- D961FN00006
- Study Id
- D961FN00006
- ClinicalTrials.gov ID
- NCT01360047
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report
-
Jul 3, 2012
